Results 271 to 280 of about 804,794 (380)

Testosterone Delays Bone Microstructural Destruction via Osteoblast‐Androgen Receptor‐Mediated Upregulation of Tenascin‐C

Advanced Science, EarlyView.
This study reveals that Testosterone–Androgen Receptor signaling delays elderly male bone destruction by upregulation of the osteoblastic extracellular tenascin‐C (TNC). The osteoprotective effect of fibrinogen C‐terminus of TNC is demonstrated in male osteoporotic mice model that osteoblast‐specific Ar‐knockout, potentially via inhibition of ...
Yong Xie, Meng Pan, Zeyuan Zhang, Licheng Zhang, Haotian Liu, Xia Wang, William W Lu, Peifu Tang, Wei Ge   +8 more
wiley   +1 more source

Is Canine Prostate-Specific Esterase a Reliable Marker for Benign Prostatic Hyperplasia Progression in Dogs? [PDF]

Animals (Basel)
Posastiuc FP, Constantin NT, Domain G, Spanoghe L, Van Soom A, Diaconescu AI, Codreanu MD.   +6 more
europepmc   +1 more source

Decision support systems for morphology‐based diagnosis and prognosis of prostate neoplasms

, 2009
Rodolfo Montironi, Liang Cheng, Antonio López-Beltrán, Roberta Mazzucchelli, Marina Scarpelli, Peter H. Bartels   +5 more
openalex   +1 more source

Ubiquitination‐Dependent LLGL2 Degradation Drives Colorectal Cancer Progression via THBS3 mRNA Stabilization

Advanced Science, EarlyView.
During the progression of CRC, MDM2, as an E3 ubiquitin ligase, promotes the degradation of the LLGL2 protein. Reduced expression of the LLGL2 protein leads to the loss of support for the CNOT1 protein, decreasing the degradation of THBS3 mRNA. The increased THBS3 further activates the PI3K‐Akt pathway, promoting the proliferation and metastasis of CRC.
Jiayan Huang, Tiantian Zhang, Huimin Li, Zidan Li, Shuangshuang Yin, Yiman Liu, Chunze Zhang, Yuling Qiu, Haiyang Yu   +8 more
wiley   +1 more source

Most of patients with localized prostate cancer will be treated in the future? | Opinion: Yes

International Brazilian Journal of Urology
Paolo Dell’Oglio, Rafael Sanchez-Salas
doaj   +1 more source

Inflammatory Myofibroblastic Tumor of the Prostate Gland: A Case Report From North-Central Nigeria. [PDF]

Cureus
Ezike KN, Okwudire-Ejeh IA, Dallang BC, Adugba EO, Ezike UN.   +4 more
europepmc   +1 more source

Expression of the SIBLINGs and their MMP partners in human benign and malignant prostate neoplasms

, 2016
C C Anunobi, Komal Koli, Geetu Saxena, A A Banjo, Kalu U.E. Ogbureke   +4 more
openalex   +2 more sources

Peptide‐Based Biomaterials as a Promising Tool for Cancer Radiotherapy

Advanced Science, EarlyView.
This review provides a systematic overview of peptide‐based biomaterials in tumor radiotherapy, covering their roles as both radiosensitizers and radiopharmaceuticals. Peptide‐based radiosensitizers are generally divided into three categories: peptides as direct radiosensitizers, peptides as carriers of radiosensitizers, and targeted‐peptide‐modified ...
Qian Wang, Xinhui Chu, Jianfeng Liu
wiley   +1 more source

Prostate puzzle: Unconventional prostatic STUMP findings in a middle-aged patient prompt closer examination. [PDF]

Radiol Case Rep
Elhaie M, Koozari A, Khademi MR.
europepmc   +1 more source

Glycolytic Enzyme HK2 Phosphorylates nSMase1 to Promote Astrocytic Exosomes Biogenesis Contributing to Acute Ischemic Stroke Injury

Advanced Science, EarlyView.
This study reveals that the glycolytic enzyme HK2 mediates hypoxia‐induced astrocytic exosome biogenesis by directly phosphorylating nSMase1. These astrocytic exosomes impair brain endothelial tight junctions. Astrocyte‐specific knockdown of HK2 reduces exosome release and alleviates brain injury after MCAO.
Chen Chen, YuWei Zhou, LongXiang Sheng, FangYing Mai, YuXuan Ding, ShiRan Hong, JiaXin Wu, JiaKai Pi, GuangMei Yan, YiJun Huang, JingJing Duan, Xuefeng Hua, Wei Yin   +12 more
wiley   +1 more source